South Korea
· Delayed Price · Currency is KRW ChoA Pharmaceutical Co., LTD. Statistics
Total Valuation
ChoA Pharmaceutical Co., LTD. has a market cap or net worth of KRW 42.41 billion. The enterprise value is 56.67 billion.
| Market Cap | 42.41B |
| Enterprise Value | 56.67B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ChoA Pharmaceutical Co., LTD. has 30.98 million shares outstanding. The number of shares has decreased by -0.64% in one year.
| Shares Outstanding | 30.98M |
| Shares Change (YoY) | -0.64% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | 20.00% |
| Owned by Institutions (%) | 0.21% |
| Float | 24.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 1.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.40 |
| EV / Sales | 0.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.57 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 70.37.
| Current Ratio | 1.36 |
| Quick Ratio | 0.90 |
| Debt / Equity | 70.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.98 |
| Interest Coverage | -11.19 |
Financial Efficiency
Return on equity (ROE) is -31.36% and return on invested capital (ROIC) is -10.85%.
| Return on Equity (ROE) | -31.36% |
| Return on Assets (ROA) | -8.83% |
| Return on Capital (ROIC) | -10.85% |
| Revenue Per Employee | 236.56M |
| Profits Per Employee | -49.96M |
| Employee Count | 258 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.93% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.93% |
| 50-Day Moving Average | 1,462.70 |
| 200-Day Moving Average | 1,698.77 |
| Relative Strength Index (RSI) | 37.54 |
| Average Volume (20 Days) | 30,672 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ChoA Pharmaceutical Co., LTD. had revenue of KRW 61.03 billion and -12.89 billion in losses. Loss per share was -419.49.
| Revenue | 61.03B |
| Gross Profit | 21.24B |
| Operating Income | -11.19B |
| Pretax Income | -13.40B |
| Net Income | -12.89B |
| EBITDA | -8.62B |
| EBIT | -11.19B |
| Loss Per Share | -419.49 |
Balance Sheet
The company has 8.22 billion in cash and 24.99 billion in debt, giving a net cash position of -16.77 billion or -541.25 per share.
| Cash & Cash Equivalents | 8.22B |
| Total Debt | 24.99B |
| Net Cash | -16.77B |
| Net Cash Per Share | -541.25 |
| Equity (Book Value) | 35.52B |
| Book Value Per Share | 1,237.39 |
| Working Capital | 11.70B |
Cash Flow
In the last 12 months, operating cash flow was -3.60 billion and capital expenditures -573.41 million, giving a free cash flow of -4.18 billion.
| Operating Cash Flow | -3.60B |
| Capital Expenditures | -573.41M |
| Free Cash Flow | -4.18B |
| FCF Per Share | -134.81 |
Margins
Gross margin is 34.80%, with operating and profit margins of -18.33% and -21.12%.
| Gross Margin | 34.80% |
| Operating Margin | -18.33% |
| Pretax Margin | -21.96% |
| Profit Margin | -21.12% |
| EBITDA Margin | -14.12% |
| EBIT Margin | -18.33% |
| FCF Margin | -6.84% |
Dividends & Yields
ChoA Pharmaceutical Co., LTD. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.64% |
| Shareholder Yield | 0.64% |
| Earnings Yield | -30.64% |
| FCF Yield | -9.85% |
Stock Splits
The last stock split was on April 21, 2003. It was a forward split with a ratio of 10.
| Last Split Date | Apr 21, 2003 |
| Split Type | Forward |
| Split Ratio | 10 |